The Oncosearch | Oncotarget

Structural characterization and in vivo pro-tumor properties of a highly conserved matrikine Research Paper

Jordan Da silva, Pedro Lameiras, Abdelilah Beljebbar, Alexandre Berquand, Matthieu Villemin, Laurent Ramont, Sylvain Dukic, Jean-Marc Nuzillard, Michael Molinari, Mathieu Gautier, Sylvie Brassart-Pasco, Bertrand Brassart

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17839-17857

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer Research Paper

Ryosuke Tanino, Yukari Tsubata, Nanae Harashima, Mamoru Harada, Takeshi Isobe

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16807-16821

Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells Research Paper

Daniela Catanzaro, Silvia Nicolosi, Veronica Cocetta, Marika Salvalaio, Andrea Pagetta, Eugenio Ragazzi, Monica Montopoli, Gianfranco Pasut

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16847-16860

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas Research Paper

Stefania Acciardo, Lionel Mignion, Nicolas Joudiou, Caroline Bouzin, Jean-FranÃ§ois Baurain, Bernard Gallez, BÃ©nÃ©dicte F. Jordan

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16832-16846

Competitive docking model for prediction of the human nicotinic acetylcholine receptor α7 binding of tobacco constituents Research Paper

Hui Wen Ng, Carmine Leggett, Sugunadevi Sakkiah, Bohu Pan, Hao Ye, Leihong Wu, Chandrabose Selvaraj, Weida Tong, Huixiao Hong

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16899-16916

High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis Research Paper

Thenappan Chandrasekar, Zachary Klaassen, Hanan Goldberg, Rashid K. Sayyid, Neil E. Fleshner

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16731-16743

Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma Clinical Research Papers

Yoshiaki Yamamoto, Ryouichi Tsunedomi, Yusuke Fujita, Toru Otori, Mitsuyoshi Ohba, Yoshihisa Kawai, Hiroshi Hirata, Hiroaki Matsumoto, Jun Haginaka, Shigeo Suzuki, Rajvir Dahiya, Yoshihiko Hamamoto, Kenji Matsuyama, Shoichi Hazama, Hiroaki Nagano, Hideyasu Matsuyama

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 17160-17170

Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer Research Paper

Felix Bremmer, Hubertus Jarry, Valerie Unterkircher, Silke Kaulfuss, Peter Burfeind, Heinz-Joachim Radzun, Philipp StrÃ¶bel, Paul Thelen

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16951-16961

Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drugâˆ’induced DNA double strand breaks from DNA double strand breaks associated with apoptosis Research Paper

Angie B. Dull, Deborah Wilsker, Melinda Hollingshead, Christina Mazcko, Christina M. Annunziata, Amy K. LeBlanc, James H. Doroshow, Robert J. Kinders, Ralph E. Parchment

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 17104-17116

⁸⁹Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I Research Paper

Rufael Chekol, Viswas Raja Solomon, Elahe Alizadeh, Wendy Bernhard, Darrell Fisher, Wayne Hill, Kris Barreto, John Francis DeCoteau, Angel Casaco Parada, Clarence Ronald Geyer, Humphrey Fonge

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 17117-17132

Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression Review

Tsung-Chieh Lin, Kuan-Wei Huang, Chia-Wei Liu, Yu-Chan Chang, Wei-Ming Lin, Tse-Yen Yang, Michael Hsiao

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 17210-17219

Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma Research Paper

Anna Tutusaus, Milica Stefanovic, Loreto Boix, Blanca Cucarull, Aynara Zamora, Laura Blasco, Pablo GarcÃa de Frutos, Maria Reig, Jose C. Fernandez-Checa, Montserrat MarÃ, Anna Colell, Jordi Bruix, Albert Morales

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16701-16717

Anti-cancerous effect of cis-khellactone from Angelica amurensis through the induction of three programmed cell deaths Research Paper

Samil Jung, Hyung-In Moon, Beom Suk Lee, Subeen Kim, Nguyen Thi Ngoc Quynh, Jimin Yu, Dan-Diem Thi Le, Zolzaya Sandag, Hyegyeong Lee, Hyojeong Lee, Nguyen Hai Anh, Young Yang, Jong-Seok Lim, Keun-Il Kim, Myeong-Sok Lee

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16744-16757

STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma Research Paper

Haley M. Simpson, Aki Furusawa, Kavitha Sadashivaiah, Curt I. Civin, Arnob Banerjee

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16792-16806

Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment Research Paper

Yoko Ogino, Akira Sato, Fumiaki Uchiumi, Sei-Ichi Tanuma

Published Mar 27, 2018 · Vol. 9, No. 23 · pp. 16451-16461

Molecular mechanism of action and potential biomarkers of growth inhibition of synergistic combination of afatinib and dasatinib against gefitinib-resistant non-small cell lung cancer cells Research Paper

Miao Wang, Alex Yuang-chi Chang

Published Mar 27, 2018 · Vol. 9, No. 23 · pp. 16533-16546

Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines Research Paper

Kazuaki Machioka, Kouji Izumi, Yoshifumi Kadono, Hiroaki Iwamoto, Renato Naito, Tomoyuki Makino, Suguru Kadomoto, Ariunbold Natsagdorj, Evan T. Keller, Jian Zhang, Atsushi Mizokami

Published Mar 23, 2018 · Vol. 9, No. 22 · pp. 16185-16196

Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells Research Paper

Richard Wilson, Jac C. Charlesworth, Lynn M. Corcoran, Anthony T. Papenfuss, Bruce A. Lyons, Gregory M. Woods, Cesar Tovar

Published Mar 23, 2018 · Vol. 9, No. 22 · pp. 15895-15914

Pingyangmycin inhibits glycosaminoglycan sulfation in both cancer cells and tumor tissues Research Paper

Ying Lan, Xiulian Li, Yong Liu, Yanli He, Haibo Yu, Cui Hao, Hua Wang, Ni Song, Sumei Ren, Liying Jin, Guoqing Zhang, Yunliang Guo, Lijuan Zhang

Published Mar 22, 2018

New antimicrobial peptide kills drug-resistant pathogens without detectable resistance Research Paper

Jong-Kook Lee, Tudor Luchian, Yoonkyung Park

Published Mar 20, 2018 · Vol. 9, No. 21 · pp. 15616-15634

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Structural characterization and in vivo pro-tumor properties of a highly conserved matrikine Research Paper

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer Research Paper

Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells Research Paper

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas Research Paper

Competitive docking model for prediction of the human nicotinic acetylcholine receptor α7 binding of tobacco constituents Research Paper

High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis Research Paper

Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma Clinical Research Papers

Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer Research Paper

Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drugâˆ’induced DNA double strand breaks from DNA double strand breaks associated with apoptosis Research Paper

⁸⁹Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I Research Paper

Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression Review

Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma Research Paper

Anti-cancerous effect of cis-khellactone from Angelica amurensis through the induction of three programmed cell deaths Research Paper

STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma Research Paper

Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment Research Paper

Molecular mechanism of action and potential biomarkers of growth inhibition of synergistic combination of afatinib and dasatinib against gefitinib-resistant non-small cell lung cancer cells Research Paper

Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines Research Paper

Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells Research Paper

Pingyangmycin inhibits glycosaminoglycan sulfation in both cancer cells and tumor tissues Research Paper

New antimicrobial peptide kills drug-resistant pathogens without detectable resistance Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Structural characterization and in vivo pro-tumor properties of a highly conserved matrikine Research Paper

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer Research Paper

Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells Research Paper

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas Research Paper

Competitive docking model for prediction of the human nicotinic acetylcholine receptor α7 binding of tobacco constituents Research Paper

High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis Research Paper

Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma Clinical Research Papers

Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer Research Paper

Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drugâˆ’induced DNA double strand breaks from DNA double strand breaks associated with apoptosis Research Paper

89Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I Research Paper

Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression Review

Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma Research Paper

Anti-cancerous effect of cis-khellactone from Angelica amurensis through the induction of three programmed cell deaths Research Paper

STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma Research Paper

Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment Research Paper

Molecular mechanism of action and potential biomarkers of growth inhibition of synergistic combination of afatinib and dasatinib against gefitinib-resistant non-small cell lung cancer cells Research Paper

Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines Research Paper

Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells Research Paper

Pingyangmycin inhibits glycosaminoglycan sulfation in both cancer cells and tumor tissues Research Paper

New antimicrobial peptide kills drug-resistant pathogens without detectable resistance Research Paper

⁸⁹Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I Research Paper